Clinical Trials Browser

Phase 1 × Esophageal Neoplasms × elgemtumab × Clear all

NCT01822613 2020-12-19

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)

Phase 1 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms